Chicago Capital Portfolio holdings
Chicago Capital, known as Chi-Cap, is a wealth management firm that focuses on helping families pursue financial goals that span generations. David Mabie and Eric Maddix started it in 2018 after years as portfolio managers and researchers at William Blair and Stein Roe, and they are two of its managing partners. Client portfolios are built for the long term from stocks, bonds, publicly traded partnerships, mutual funds and ETFs. Chi-Cap also runs the Armitage Focused Equity Strategy, whose holdings it shares as research with institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$100M |
| 2 |
ExxonMobil
XOM
|
+$48M |
| 3 |
Seagate
STX
|
+$16.9M |
| 4 |
GE Vernova
GEV
|
+$14.7M |
| 5 |
Palantir
PLTR
|
+$8.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insulet
PODD
|
+$35.4M |
| 2 |
Procept Biorobotics
PRCT
|
+$31.5M |
| 3 |
Fair Isaac
FICO
|
+$17M |
| 4 |
CoStar Group
CSGP
|
+$14.8M |
| 5 |
Intuit
INTU
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.95% |
| 2 | Healthcare | 16.22% |
| 3 | Industrials | 13.28% |
| 4 | Financials | 11.56% |
| 5 | Communication Services | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
iShares Core S&P Total US Stock Market ETF
ITOT
$95.5B
| $1.66M | 0.04% |
9,962
| – | – |
2024 Q1
10 quarters
|
|
152
Edwards Lifesciences
EW
$61.6B
| $1.64M | 0.04% |
18,984
| – | – |
2018 Q1
34 quarters
|
|
153
Automatic Data Processing
ADP
$122B
| $1.64M | 0.04% |
6,338
| – | – |
2018 Q1
34 quarters
|
|
154
Okta
OKTA
$32B
| $1.63M | 0.04% |
+7,816
| New | +$1.24M |
2026 Q3
0 quarters
|
|
155
Marriott International
MAR
$109B
| $1.62M | 0.04% |
4,553
-11
| -0.2% | -$3.92K |
2018 Q1
34 quarters
|
|
156
iShares Russell 1000 Growth ETF
IWF
$118B
| $1.58M | 0.04% |
12,599
+345
| +3% | +$42.2K |
2018 Q1
34 quarters
|
|
157
Vanguard Total Bond Market
BND
$165B
| $1.56M | 0.04% |
22,236
+41
| +0.2% | +$2.96K |
2025 Q1
6 quarters
|
|
158
iShares Russell 2000 Growth ETF
IWO
$13.9B
| $1.55M | 0.04% |
4,346
-123
| -3% | -$46.4K |
2018 Q1
34 quarters
|
|
159
Union Pacific
UNP
$180B
| $1.51M | 0.04% |
5,563
+147
| +3% | +$42.7K |
2018 Q1
34 quarters
|
|
160
Charles Schwab
SCHW
$160B
| $1.51M | 0.04% |
15,472
-55
| -0.4% | -$5.79K |
2024 Q2
9 quarters
|
|
161
Ziff Davis
ZD
$1.7B
| $1.51M | 0.04% |
26,647
| – | – |
2018 Q4
31 quarters
|
|
162
Zoetis
ZTS
$34.1B
| $1.51M | 0.03% |
21,573
+3,075
| +17% | +$230K |
2018 Q1
34 quarters
|
|
163
TJX Companies
TJX
$148B
| $1.51M | 0.03% |
11,380
-8,047
| -41% | -$1.16M |
2018 Q2
33 quarters
|
|
164
Tyler Technologies
TYL
$16.9B
| $1.49M | 0.03% |
4,687
+874
| +23% | +$288K |
2023 Q4
11 quarters
|
|
165
Shell
SHEL
$280B
| $1.46M | 0.03% |
15,404
-777
| -5% | -$70.1K |
2022 Q1
18 quarters
|
|
166
PPG Industries
PPG
$27.1B
| $1.45M | 0.03% |
13,929
+300
| +2% | +$33.9K |
2025 Q1
6 quarters
|
|
167
Honeywell
HON
$70.6B
| $1.44M | 0.03% |
6,844
-4,339
| -39% | -$968K |
2018 Q1
34 quarters
|
|
168
Estee Lauder
EL
$40.5B
| $1.44M | 0.03% |
15,513
-100
| -0.6% | -$9.1K |
2025 Q1
6 quarters
|
|
169
Block Inc
XYZ
$51.1B
| $1.43M | 0.03% |
19,501
| – | – |
2024 Q1
10 quarters
|
|
170
Lam Research
LRCX
$283B
| $1.41M | 0.03% |
4,291
| – | – |
2025 Q1
6 quarters
|
|
171
Camden Property Trust
CPT
$9.9B
| $1.37M | 0.03% |
14,214
+3,505
| +33% | +$379K |
2025 Q1
6 quarters
|
|
172
Pfizer
PFE
$165B
| $1.35M | 0.03% |
47,424
-669
| -1% | -$17.8K |
2018 Q1
34 quarters
|
|
173
Air Products & Chemicals
APD
$70.5B
| $1.33M | 0.03% |
4,783
+675
| +16% | +$201K |
2018 Q1
34 quarters
|
|
174
Comcast
CMCSA
$89.3B
| $1.32M | 0.03% |
60,800
+2,112
| +4% | +$51.7K |
2018 Q1
34 quarters
|
|
175
Accenture
ACN
$148B
| $1.32M | 0.03% |
7,197
-200
| -3% | -$33.8K |
2019 Q1
30 quarters
|
|
Similar funds
Chicago Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Chicago Capital held 390 positions worth $4.32B, up 4% from $4.15B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Chicago Capital's Q3 2026 filing shows 29 new, 126 increased, 116 reduced and 18 closed positions. Its largest new stake was ExxonMobil: 306,714 shares worth $49.9M. The largest sale was Insulet, an estimated $35.4M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Chicago Capital's largest Q3 2026 buy was ExxonMobil: 306,714 shares worth $49.9M.
- Chicago Capital added most to SpaceX in Q3 2026, an estimated $100M increase.
- Chicago Capital's biggest Q3 2026 reduction was Insulet, cutting an estimated $35.4M.
- Chicago Capital fully exited Arthur J. Gallagher & Co in Q3 2026, selling an estimated $2.31M.
- Chicago Capital's ten largest holdings make up 38% of its $4.32B portfolio in Q3 2026.
- Chicago Capital opened 29 new positions and closed 18 in Q3 2026.
- Chicago Capital's portfolio value rose 4% quarter-over-quarter to $4.32B.
Based on Chicago Capital's 13F filing for Q3 2026, filed 13 Oct 2026.